{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:48:42Z","timestamp":1759366122044,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gaceta Sanitaria"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.gaceta.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T11:03:08Z","timestamp":1555326188000},"page":"157-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Influencia de la v\u00eda diagn\u00f3stica en la cl\u00ednica y el uso de terapias no convencionales en mujeres con c\u00e1ncer de mama de la cohorte DAMA"],"prefix":"10.1016","volume":"34","author":[{"given":"Isabel","family":"Tor\u00e1-Rocamora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Oliver-Vall-llosera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Bargall\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Aldea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Puigpin\u00f3s-Riera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gaceta.2019.02.006_bib0180","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S Preventive Services Task Force recommendation statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ypmed.2011.05.011","article-title":"The evidence base for breast cancer screening","volume":"53","author":"Glasziou","year":"2011","journal-title":"Prev Med."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0195","first-page":"15","article-title":"Breast cancer","volume":"30","author":"Pearce","year":"2016","journal-title":"Nurs Stand."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02711439","article-title":"Variations in use of breast-conserving surgery by patient, hospital characteristics, and region: a multilevel analysis","volume":"3","author":"Peris Tuser","year":"2001","journal-title":"Rev Oncol."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1157\/13096936","article-title":"C\u00e1ncer de mama diagnosticado mediante un programa de detecci\u00f3n preco. \u00bfDifiere del diagnosticado en el marco asistencial habitual?","volume":"128","author":"Naveiro-Rilo","year":"2007","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0033-8338(04)77982-5","article-title":"C\u00e1ncer de intervalo. Experiencia en el Programa de Prevenci\u00f3n de C\u00e1ncer de Mama de Navarra (1990-2000)","volume":"46","author":"Mellado","year":"2004","journal-title":"Radiologia."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0215","unstructured":"Direcci\u00f3n General de Organizaci\u00f3n de las Prestaciones Sanitarias. Consejer\u00eda de Salud y Servicios Sanitarios del Principado de Asturias. Gu\u00eda de recomendaciones cl\u00ednicas. C\u00e1ncer de mama. 2005; AS-5069-2005. (Consultado el 6\/2\/2019.) Disponible en: https:\/\/www.astursalud.es\/documents\/31867\/36144\/PCAI_4+CANCER+DE+MAMA.pdf\/08829281-a8a1-1ed8-bbb1-ddbed2b7db90"},{"key":"10.1016\/j.gaceta.2019.02.006_bib0220","first-page":"1","article-title":"Diagn\u00f3stico y tratamiento del c\u00e1ncer de mama","author":"Guerra","year":"2007","journal-title":"Gu\u00eda cl\u00ednica."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0225","first-page":"183","article-title":"Complicaciones debidas al tratamiento oncol\u00f3gico que afectan a la nutrici\u00f3n. En: Soporte nutricional en el paciente oncol\u00f3gico","author":"Toral Pe\u00f1a","year":"2004","journal-title":"Cap\u00edtulo XIV."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0230","first-page":"1","article-title":"Toxicidad de los tratamientos oncol\u00f3gicos","author":"Blasco","year":"2016","journal-title":"Sociedad Espa\u00f1ola de Oncolog\u00eda M\u00e9dica."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4321\/S1131-57682002000700002","article-title":"Atenci\u00f3n a los efectos secundarios de la radioterapia","volume":"12","author":"Verd\u00fa Rotellar","year":"2002","journal-title":"Medifam."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0240","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.soc.2010.03.006","article-title":"Adjuvant hormonal therapy for early-stage breast cancer","volume":"19","author":"Burstein","year":"2010","journal-title":"Surg Oncol Clin N Am."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ctim.2012.04.002","article-title":"Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer","volume":"20","author":"Saquib","year":"2012","journal-title":"Complement Ther Med."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0250","unstructured":"Instituto Nacional del C\u00e1ncer. Terapias integrales, alternativas y complementarias (PDQ\u00ae) - Versi\u00f3n para profesionales de salud. Instituto Nacional del C\u00e1ncer. 2016. (Consultado el 6\/2\/2019.) Disponible en: https:\/\/www.cancer.gov\/espanol\/cancer\/tratamiento\/mca\/pro\/temas-mca-pdq."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0255","unstructured":"Office of Cancer Complementary and Alternative Medicine. Complementary and Alternative Medicine (CAM). (Consultado el 6\/2\/2019.) Disponible en: https:\/\/www.cancer.gov\/about-cancer\/treatment\/cam."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0260","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00404-017-4348-2","article-title":"Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network","volume":"295","author":"Fremd","year":"2017","journal-title":"Arch Gynecol Obstet."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0265","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.2196\/resprot.7653","article-title":"Influence of social determinants, lifestyle, emotional well-being and the use of unconventional therapies in breast cancer progression in a cohort of women in Barcelona: protocol for the DAMA Cohort","volume":"6","author":"Puigpin\u00f3s-Riera","year":"2017","journal-title":"JMIR Res Protoc."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0270","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1089\/jwh.2010.2478","article-title":"Evolution of inequalities in breast and cervical cancer screening in Barcelona: population surveys 1992, 2001, and 2006","volume":"20","author":"Puigpin\u00f3s-Riera","year":"2011","journal-title":"J Womens Health (Larchmt)."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0275","first-page":"93","article-title":"Desigualdades en la realizaci\u00f3n de mamograf\u00edas y citolog\u00edas cervicales en las mujeres espa\u00f1olas seg\u00fan las encuestas nacionales de salud","volume":"30","author":"Serral","year":"2017","journal-title":"Rev Senol y Patol Mamar."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gaceta.2016.12.010","article-title":"Desigualdades socioecon\u00f3micas en el control mamogr\u00e1fico en mujeres espa\u00f1olas de 45 a 69 a\u00f1os de edad","volume":"32","author":"Serral","year":"2018","journal-title":"Gac Sanit."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0285","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3961\/jpmph.2008.41.3.186","article-title":"Socioeconomic disparities in breast cancer screening among US women: trends from 2000 to 2005","volume":"41","author":"Kim","year":"2008","journal-title":"J Prev Med Public Health."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/annonc\/mdj007","article-title":"Origins of socio-economic inequalities in cancer survival: a review","volume":"17","author":"Woods","year":"2006","journal-title":"Ann Oncol."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0295","first-page":"13","article-title":"Estudio comparativo de la supervivencia del c\u00e1ncer de mama seg\u00fan diagn\u00f3stico asistencial versus programa de detecci\u00f3n precoz","volume":"29","author":"Salvad\u00f3-Usach","year":"2016","journal-title":"Rev Senol Patol Mamar."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0300","first-page":"149","article-title":"El c\u00e1ncer de mama diagnosticado mediante un programa de detecci\u00f3n precoz difiere del diagnosticado en el marco cl\u00ednico asistencial habitual","volume":"39","author":"G\u00f3mez-Calvo","year":"2012","journal-title":"Clin Invest Ginecol Obstet."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0305","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/jnci\/dji206","article-title":"American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome","volume":"97","author":"Carey","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0310","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-012-2162-x","article-title":"Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program","volume":"135","author":"Hofvind","year":"2012","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0315","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0320","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0212-6567(00)78693-8","article-title":"Prevenci\u00f3n del c\u00e1ncer de mama en atenci\u00f3n primaria","volume":"26","author":"Cameselle Teijeiro","year":"2000","journal-title":"Aten Primaria."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0325","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12282-016-0694-3","article-title":"Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer","volume":"24","author":"Meattini","year":"2017","journal-title":"Breast Cancer."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0330","first-page":"260","article-title":"Complementary and alternative medicine use in breast cancer patients in Europe","volume":"14","author":"Molassiotis","year":"2006","journal-title":"Support Care Cancer."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0335","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.ejca.2012.04.021","article-title":"Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study","volume":"48","author":"Tautz","year":"2012","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0340","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10549-009-0315-3","article-title":"Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study","volume":"117","author":"Greenlee","year":"2009","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.gaceta.2019.02.006_bib0345","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12906-015-0969-9","article-title":"Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study","volume":"15","author":"Naja","year":"2015","journal-title":"BMC Complement Altern Med."},{"year":"2009","series-title":"Medicina integrativa","author":"Prakel","key":"10.1016\/j.gaceta.2019.02.006_bib0350"}],"container-title":["Gaceta Sanitaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911119300780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213911119300780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:18:47Z","timestamp":1759324727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213911119300780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0213911119300780"],"URL":"https:\/\/doi.org\/10.1016\/j.gaceta.2019.02.006","relation":{},"ISSN":["0213-9111"],"issn-type":[{"type":"print","value":"0213-9111"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influencia de la v\u00eda diagn\u00f3stica en la cl\u00ednica y el uso de terapias no convencionales en mujeres con c\u00e1ncer de mama de la cohorte DAMA","name":"articletitle","label":"Article Title"},{"value":"Gaceta Sanitaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gaceta.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SESPAS. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}